The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Germ-line BRCA mutations in high-grade ovarian cancer: A case for routine BRCA mutation screening after a diagnosis of invasive ovarian cancer.
K. Alsop
No relevant relationships to disclose
S. Fereday
No relevant relationships to disclose
C. Meldrum
No relevant relationships to disclose
A. deFazio
No relevant relationships to disclose
P. Webb
No relevant relationships to disclose
M. J. Birrer
No relevant relationships to disclose
M. Friedlander
No relevant relationships to disclose
S. B. Fox
No relevant relationships to disclose
D. Bowtell
No relevant relationships to disclose
G. Mitchell
No relevant relationships to disclose